ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALIM Alimera Sciences Inc

3.90
0.00 (0.00%)
Pre Market
Last Updated: 04:16:42
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 3.63
Ask Price 6.19
News -
Day High

Low
1.56

52 Week Range

High
4.40

Day Low
Company Name Stock Ticker Symbol Market Type
Alimera Sciences Inc ALIM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 3.90 04:16:42
Open Price Low Price High Price Close Price Prev Close
3.90
Trades Volume Avg Volume 52 Week Range
0 0 - 1.56 - 4.40
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 3.90 USD

Alimera Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
204.18M 52.35M - 54.13M -18.11M -0.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alimera Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ALIM Message Board. Create One! See More Posts on ALIM Message Board See More Message Board Posts

Historical ALIM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.894.23993.773.97103,6170.010.26%
1 Month3.404.403.293.9990,6610.5014.71%
3 Months3.904.403.073.7982,5240.000.00%
6 Months3.234.402.603.7574,7620.6720.74%
1 Year1.804.401.562.74204,9902.10116.67%
3 Years9.4611.84991.303.4690,160-5.56-58.77%
5 Years1.0912.250.00032.80109,0662.81257.80%

Alimera Sciences Description

Alimera Sciences is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN(R) is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. A $2B global market, DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema leading to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology.

Your Recent History

Delayed Upgrade Clock